Damora Therapeutics, Inc. - Ordinary Shares (DMRA)

27.94
-0.24 (-0.85%)
NASDAQ· Last Trade: Sep 3rd, 10:16 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Why This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surgefool.com
This clinical-stage biotech develops small molecule therapies for cancer and fibrotic diseases, focusing on galectin-3 and LOXL2 inhibitors.
Via The Motley Fool · May 30, 2026